MannKind Corp (USD)
MNKD
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.14 | 1.22
52-Wk Range0.94 | 2.34
Last Close1.19
Mkt Cap (m)245.63
Dividend yield-
ISINUS56400P7069
Volume2,659,758
Exchange VenueNAS

Company Profile

MannKind Corp is engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer. Its products and technologies include Afrezza, Dry powder formulation, Inhalation profiling, and others.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales3.48
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -290.98
Net Margin %-312.20
Return on Equity-
Debt/Equity-

Legal Documents

Prospectus
en 07/05/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)1751228
Operating Income (m)-169-180-20465-94-81
Net Income (m)-191-198-368126-117-87
Basic EPS-3.20-2.55-4.551.37-1.13-0.60
Avg. Diluted Shares Outstanding (m)60778192104144
Balance Sheet
USD201320142015201620172018
Current Assets (m)7620177775782
Non Current Assets (m)18219350302726
Total Assets (m)25939412610785108
Current Liabilities (m)128403268928875
Total Liabilities (m)------
Total Equity (m)-31-74-350-184-215-175
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-1294-57-78-65-38
Capital Expenditure (m)-8-24-10-1-
Figures are quoted in USD unless stated otherwise
0.02 (1.68%)
$
1.21
Last Price